Rapid modification of the glycocalyx caused by ischemia-reperfusion is inhibited by adenosine A2A receptor activation

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 284, Issue 6 53-6, 2003, Pages

  Platts, Steven H ^a   Linden, Joel ^a   Duling, Brian R ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Capillary; Endothelium; Inflammation; Mast cell; Permeability

Indexed keywords

4 [2 [7 AMINO 2 (2 FURYL) 1,2,4 TRIAZOLO[2,3 A][1,3,5]TRIAZIN 5 YLAMINO]ETHYL]PHENOL; 4 [3 [6 AMINO 9 (5 ETHYLCARBAMOYL 3,4 DIHYDROXYTETRAHYDRO 2 FURYL) 9H PURIN 2 YL] 2 PROPYNYL]CYCLOHEXANECARBOXYLIC ACID METHYL ESTER; ADENOSINE A2 RECEPTOR ANTAGONIST; ADENOSINE A2A RECEPTOR; ADENOSINE A2A RECEPTOR AGONIST; DEXTRAN 70; DYE; FLUORESCEIN ISOTHIOCYANATE; SUXAMETHONIUM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL; BLOOD VESSEL PERMEABILITY; CAPILLARY; CAPILLARY ENDOTHELIUM; CONTROLLED STUDY; CREMASTER MUSCLE; DISEASE ASSOCIATION; ERYTHROCYTE; GLYCOCALYX; HEART MUSCLE ISCHEMIA; INFLAMMATION; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN STRUCTURE; REPERFUSION INJURY; VENULE;

EID: 0038781831     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00899.2002     Document Type: Article

References (50)

1. Adamson RH. Increased permeability of mesenteric capillaries of pithed frogs associated with mild protease digestion of the endothelial glycocalyx. J Physiol 407: 27P, 1988.
2. Adamson RH. Permeability of frog mesenteric capillaries after partial pronase digestion of the endothelial glycocalyx. J Physiol 428: 1-13, 1990.
3. Baldwin AL and Winlove CP. Effects of perfusate composition on binding of ruthenium red and gold colloid to glycocalyx of rabbit aortic endothelium. J Histochem Cytochem 32: 259-266, 1984.
4. Bardenheuer H and Schrader J. Supply-to-demand ratio for oxygen determines formation of adenosine by the heart. Am J Physiol Heart Circ Physiol 250: H173-H180, 1986.
5. Beresewicz A, Czarnowska E, and Maczewski M. Ischemic preconditioning and superoxide dismutase protect against endothelial dysfunction and endothelium glycocalyx disruption in the postischemic guinea-pig hearts. Mol Cell Biochem 186: 87-97, 1998.
6. Birdsell DC, Doyle RJ, and Morgenstern M. Organization of teichoic acid in the cell wall of Bacillus subtilis. J Bacteriol 121: 726-734, 1975.
7. 2 receptors to inhibit neutrophil adhesion and injury to isolated cardiac myocytes. J Immunol 155: 2579-2586, 1995.
8. Carden DL and Granger DN. Pathophysiology of ischaemia-reperfusion injury. J Pathol 190: 255-266, 2000.
9. Caro CG, Pedley TJ, Schroter RC, and Seed WA. The systemic circulation. In: The Mechanics of the Circulation. Oxford: Oxford Univ. Press, 1978, p. 351-433.
10. 2A agonist, ATL-146e, reduces paralysis and apoptosis during rabbit spinal cord reperfusion. J Vasc Surg 34: 482-488, 2001.
11. 2A analog ATL-146e reduces systemic tumor necrosing factor-alpha and spinal cord capillary platelet-endothelial cell adhesion molecule-1 expression after spinal cord ischemia. J Vasc Surg 35: 994-998, 2002.
12. Collard CD and Gelman S. Pathophysiology, clinical manifestations, and prevention of ischemia-reperfusion injury. Anesthesiology 94: 1133-1138, 2001.
13. Constantinescu AA, Vink H, and Spaan JA. Elevated capillary tube hematocrit reflects degradation of endothelial cell glycocalyx by oxidized LDL. Am J Physiol Heart Circ Physiol 280: H1051-H1057, 2001.
14. Cronstein BN. Adenosine, an endogenous anti-inflammatory agent. J Appl Physiol 76: 5-13, 1994.
15. Cronstein BN, Levin RI, Belanoff J, Weissmann G, and Hirschorn R. Adenosine: an endogenous inhibitor of neutrophil-mediated injury to endothelial cells. J Clin Invest 78: 760-770, 1986.
16. 2 receptors. J Immunol 148: 2201-2206, 1992.
17. Czarnowska E and Karwatowska-Prokopczuk E. Ultrastructural demonstration of endothelial glycocalyx disruption in the reperfused rat heart Involvement of oxygen free radicals. Basic Res Cardiol 90: 357-364, 1995.
18. Czarnowska E and Karwatowska-Prokopczuk E. Role of oxygen free radicals in cardiocyte injury in the reperfused rat heart. Folia Histochem Cytobiol 34, Suppl 1: 25-26, 1996.
19. Czarnowska E, Kurzelewski M, Beresewicz A, and Karczmarewicz E. The role of endogenous nitric oxide in inhibition of ischemia/reperfusion-induced cardiomyocyte apoptosis. Folia Histochem Cytobiol 39: 179-180, 2001.
20. De Jong JW, de Jonge R, Keijzer E, and Bradamante S. The role of adenosine in preconditioning. Pharmacol Ther 87: 141-149, 2000.
21. Desjardins C and Duling BR, Heparinase treatment suggests a role for the endothelial cell glycocalyx in regulation of capillary hematocrit. Am J Physiol Heart Circ Physiol 258: H647-H654, 1990.
22. Dhalla NS, Elmoselhi AB, Hata T, and Makino N. Status of myocardial antioxidants in ischemia-reperfusion injury. Cardiovasc Res 47: 446-456, 2000.
23. Doyle MP, Linden J, and Duling BR. Nucleoside-induced arteriolar constriction: a mast cell-dependent response. Am J Physiol Heart Circ Physiol 266: H2042-H2050, 1994.
24. 2 alpha receptors inhibits mast cell degranulation and mast cell-dependent vasoconstriction. Microcirculation 7: 129-135, 2000.
25. Firestein GS, Bullough DA, Erion MD, Jimenez R, Ramirez-Weinhouse M, Barankiewicz J, Smith CW, Gruber HE, and Mullane KM. Inhibition of neutrophil adhesion by adenosine and an adenosine kinase inhibitor. The role of selectins. J Immunol 154: 326-334, 1995.
26. Frangogiannis NG, Smith CW, and Entman ML. The inflammatory response in myocardial infarction. Cardiovasc Res 53: 31-47, 2002.
27. 2A adenosine receptor agonists ATL193 and ATL146e administered by either intravenous infusion or bolus injection. Circulation 104: 1181-1187, 2001.
28. Haack DW, Bush LR, Shlafer M, and Lucchesi BR. Lanthanum staining of coronary microvascular endothelium: effects of ischemia reperfusion, propranolol, and atenolol. Microvasc Res 21: 362-376, 1981.
29. Henry CB and Duling BR. Permeation of the luminal capillary glycocalyx is determined by hyaluronan. Am J Physiol Heart Circ Physiol 277: H508-H514, 1999.
30. Henry CBS and Duling BR. TNF-a increases entry of macromolecules into the luminal endothelial cell glycocalyx. Am J Physiol Heart Circ Physiol. In press.
31. Huxley VH and Williams DA. Role of a glycocalyx on coronary arteriole permeability to proteins: evidence from enzyme treatments. Am J Physiol Heart Circ Physiol 278: H1177-H1185, 2000.
32. Ito S. Form and function of the glycocalyx on free cell surfaces. Philos Trans R Soc Lond B Biol Sci 268: 55-66, 1974.
33. Jordan JE, Zhao ZQ, and Vinten-Johansen J. The role of neutrophils in myocardial ischemia-reperfusion injury. Cardiovasc Res 43: 860-878, 1999.
34. Kanwar S, Hickey MJ, and Kubes P. Postischemic inflammation: a role for mast cells in intestine but not in skeletal muscle. Am J Physiol Gastrointest Liver Physiol 275: G212-G218, 1998.
35. Kurzelewski M, Czarnowska E, and Beresewicz A. Endothelin in the mechanism of endothelial injury and neutrophil adhesion in the post-ischemic guinea-pig heart. Eur J Pharmacol 434: 95-107, 2002.
36. Linden J. Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection. Annu Rev Pharmacol Toxicol 41: 775-787, 2001.
37. 2A receptor stimulation reduces inflammation and neointimal growth in a murine carotid ligation model. Arterioscler Thromb Vasc Biol 21: 791-796, 2001.
38. Mubagwa K and Flameng W. Adenosine, adenosine receptors and myocardial protection: an updated overview. Cardiovasc Res 52:25-39, 2001.
39. Mulivor AW and Lipowsky HH. Role of glycocalyx in leukocyte-endothelial cell adhesion. Am J Physiol Heart Circ Physiol 283: H1282-H1291, 2002.
40. 2A-adenosine receptor activation and PDE 4 inhibition Kidney Int 59: 2114-2125, 2001. [Erratum. Kidney Int 60: Aug 2001, p. 820.]
41. 2A adenosine receptor activation reduces ischemia-reperfusion injury in rat kidney. Am J Physiol Renal Physiol 277: F404-F412, 1999.
42. 2A adenosine receptor activation reduces skin pressure ulcer formation and inflammation. Am J Physiol Heart Circ Physiol 281: H67-H74, 2001.
43. Pries AR, Secomb TW, and Gaehtgens P. The endothelial surface layer. Pflügers Arch 440: 653-666, 2000.
44. Pries AR, Secomb TW, Jacobs H, Sperandio MB, Osterloh K, and Gaehtgens PAL. Microvascular blood flow resistance: role of endothelial surface layer. Am J Physiol Heart Circ Physiol 273: H2272-H2279, 1997.
45. 3 adenosine receptor. Circ Res 78: 627-634, 1996.
46. Simionescu M and Simionescu N. Functions of the endothelial cell surface. Annu Rev Physiol 48: 279-293, 1986.
47. Sims DE and Horne MM. Non-aqueous fixative preserves macromolecules on the endothelial cell surface: an in situ study. Eur J Morphol 31: 251-256, 1993.
48. Vink H, Constantinescu AA, and Spaan JA. Oxidized lipoproteins degrade the endothelial surface layer: implications for platelet-endothelial cell adhesion. Circulation 101: 1500-1502, 2000.
49. Vink H and Duling BR. Identification of distinct luminal domains for macromolecules, erythrocytes, and leukocytes within mammalian capillaries. Circ Res 79: 581-589, 1996.
50. Vink H and Duling BR. Capillary endothelial surface layer selectively reduces plasma solute distribution volume. Am J Physiol Heart Circ Physiol 278: H285-H289, 2000.